Abstract
New findings
What is the central question of this study? Are coagulation and fibrinolytic factors disrupted in Andean highlanders with excessive erythrocytosis? What is the main finding and its importance? Excessive erythrocytosis is not associated with prothombotic disruptions in coagulation or the fibrinolytic system in Andean highlanders. Impairments in coagulation and fibrinolysis may not contribute to the increased vascular risk associated with excessive erythrocytosis.Abstract
Increased coagulation and reduced fibrinolysis are central factors underlying thrombotic risk and events. High altitude-induced excessive erythrocytosis (EE) is prevalent in Andean highlanders, contributing to increased cardiovascular risk. Disruption in the coagulation-fibrinolytic axis resulting in uncontrolled fibrin deposition might underlie the increased thrombotic risk associated with high-altitude EE. The experimental aim of this study was to determine whether EE is associated with a prothrombotic blood coagulation and fibrinolytic profile in Andean highlanders. Plasma coagulation factors (von Willebrand factor and factors VII, VIII and X), fibrinolytic factors [tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1)] and D-dimer levels were determined in 26 male residents of Cerro de Pasco, Peru (4340 m a.s.l.): 12 without EE (age, 40 ± 13 years; haemoglobin, 17.4 ± 1.9 g/dl) and 14 with EE (age, 43 ± 15 years; haemoglobin, 24.4 ± 1.6 g/dl). There were no significant differences in von Willebrand factor (40.5 ± 24.8 vs. 45.5 ± 22.4%), factor VII (77.0 ± 14.5 vs. 72.5 ± 8.9%), factor VIII (55.6 ± 19.8 vs. 60.7 ± 26.8%) and factor X (73.9 ± 8.3 vs. 67.3 ± 10.9%) between the Andean highlanders without or with EE. The t-PA antigen (8.5 ± 3.6 vs. 9.6 ± 5.4 ng/ml), t-PA activity (5.5 ± 2.4 vs. 5.8 ± 1.6 IU/ml), PAI antigen (45.0 ± 33.8 vs. 40.5 ± 15.8 ng/ml), PAI-1 activity (0.24 ± 0.09 vs. 0.25 ± 0.11 IU/ml) and the molar concentration ratio of active t-PA to active PAI-1 (1:0.051 ± 0.034 vs. 1:0.046 ± 0.021 mmol/l) were also similar between the groups, as were D-dimer levels (235.0 ± 126.4 vs. 268.4 ± 173.7 ng/ml). Collectively, the results of the present study indicate that EE is not associated with a hypercoagulable, hypofibrinolytic state in Andean highlanders.Full text links
Read article at publisher's site: https://doi.org/10.1113/ep089360
Read article for free, from open access legal sources, via Unpaywall: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1113/EP089360
Citations & impact
Impact metrics
Alternative metrics
Discover the attention surrounding your research
https://www.altmetric.com/details/102267367
Article citations
Are coagulation profiles in Andean highlanders with excessive erythrocytosis favouring hypercoagulability?
Exp Physiol, 109(6):899-914, 30 Mar 2024
Cited by: 1 article | PMID: 38554124 | PMCID: PMC11140178
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Global REACH 2018: dysfunctional extracellular microvesicles in Andean highlander males with excessive erythrocytosis.
Am J Physiol Heart Circ Physiol, 320(5):H1851-H1861, 12 Mar 2021
Cited by: 4 articles | PMID: 33710927 | PMCID: PMC8163655
Excessive Erythrocytosis and Cardiovascular Risk in Andean Highlanders.
High Alt Med Biol, 19(3):221-231, 21 May 2018
Cited by: 30 articles | PMID: 29782186 | PMCID: PMC6157350
Are coagulation profiles in Andean highlanders with excessive erythrocytosis favouring hypercoagulability?
Exp Physiol, 109(6):899-914, 30 Mar 2024
Cited by: 1 article | PMID: 38554124 | PMCID: PMC11140178
New genetic and physiological factors for excessive erythrocytosis and Chronic Mountain Sickness.
J Appl Physiol (1985), 119(12):1481-1486, 13 Aug 2015
Cited by: 13 articles | PMID: 26272318 | PMCID: PMC4683346
Review Free full text in Europe PMC
Funding
Funders who supported this work.